New imaging agent could light up Hard-to-See cancers
NCT ID NCT07117214
First seen Jun 25, 2026 · Last updated Jul 08, 2026 · Updated 3 times
Summary
This early-phase study tests a new radioactive imaging agent called [68Ga]Ga-DWJ155 in 36 adults with advanced breast cancer or non-small cell lung cancer. The agent is designed to bind to a target on cancer cells and show up on PET scans, helping doctors see where the cancer has spread. The main goals are to check how well the imaging works, how the agent spreads in the body, and whether it is safe.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- [68Ga]Ga-DWJ155 (a radioactive imaging agent for PET scans)
- What this could lead to
- If successful, this could lead to a better way to detect and monitor advanced breast cancer and lung cancer using PET imaging, potentially guiding treatment decisions.
- What could go wrong
- This is a very early, first-in-human study with only 36 participants. The imaging agent may not clearly distinguish tumors from normal tissue, or safety issues could arise. It is not a treatment and will not directly improve outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Novartis Investigative Site
RECRUITINGGroningen, Provincie Groningen, 9728, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Step drug combo outsmart advanced HER2-Positive breast cancer?
- Smartwatch could spot nerve damage before it starts
- Can acupuncture soothe the mind and body in breast cancer?
- Can immunotherapy be safely used in early lung cancer? a Real-World study investigates
- CT scans may predict breast reconstruction flap failure
- A gentle jog might be the key to better sleep for breast cancer survivors